共 63 条
[4]
BEDI A, 1994, BLOOD, V83, P2038
[6]
Branford S, 1999, BRIT J HAEMATOL, V107, P587
[7]
Buchdunger E, 1996, CANCER RES, V56, P100
[8]
Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139
[9]
Bcr-Abl inhibition as a modality of CML therapeutics
[J].
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER,
2001, 1551 (01)
:M11-M18